Risk of blood clots after AstraZeneca Covid jab is 'small'

Britain advises that under-40s are offered alternative to AstraZeneca Covid-19 shot

And now that Health Canada has authorized the Pfizer-BioNTech product for adolescents aged 12 to 15, federal officials say they expect to have enough of that product on hand to vaccinate that younger cohort by Canada Day. In April, the JCVI advised alternatives to AstraZeneca's vaccine for those under-30.

While studies underway in the United Kingdom now are looking at whether it's practical to mix one dose of AstraZeneca with a second dose of an mRNA vaccine like Pfizer, the current federal guidance is for all recipients to get two doses of the same product.

'Those countries that delayed their own vaccination programmes at a time of high transmission rates by declining to use available Oxford/AstraZeneca vaccines should know that their decision will have contributed to an increase in the number of avoidable deaths from Covid-19'.

The vaccine has been linked to rare blood clots and last month, several European countries including Denmark and Norway, went against World Health Organisation advice and halted their rollouts amid concerns over the risks.

"I am confident that they have done the right thing to protect themselves, and our community".

"Around 1,238,000 doses of Oxford-AstraZeneca'sCOVID-19 vaccine (Covishield) are arriving on May 8 at the Islamabad Airport".

The BMJ study looked at 280,000 18-65 year-olds in Denmark and Norway who had a first dose of the AstraZeneca vaccine between the start of February and March 11. "So if anybody comes in who is in the 30 to 39 age group, they will be offered the Pfizer vaccine in the main and Moderna in some places".

"If not, then one needs to balance out the risk of COVID complications against the risk of VITT that, although rare, does exist and may lead to severe complications".

Razak said all the vaccines approved in Canada, including AstraZeneca, are good vaccines to take.

"We have to maintain the pace and scale of the United Kingdom vaccination program", Van-Tam said, noting that the AstraZeneca vaccine is safe and effective and "thousands are alive today" because they received it.

They found slightly increased rates of vein blood clots including clots in the veins of the brain, compared with expected rates in the general population.

"The likelihood of this happening is about one in 100,000 doses", she said, adding there a test and treatment for the syndrome.

"It is the first shipment of the COVID-19 vaccine being supplied through COVAX to Pakistan from a non-Indian source", the National Health Services, Regulations and Coordination official said.

Related:

Comments


Other news